气道黏液高分泌型COPD患者人群特征分析
Analysis of Demographic Characteristics in COPD Patients with Airway Mucus Hypersecretion
摘要: 目的:探究气道黏液高分泌型COPD患者的人群特征分析及其影响因素分析。方法:我们回顾性收集慢阻肺患者的一般资料、实验室及影像学检查结果,根据圣乔治呼吸问卷将患者分为高分泌型患者和非高分泌型COPD患者,从而比较两者的差异。结果:在本次研究中,共收集到84份符合纳入标准的数据,其中高分泌型COPD患者共34人。高分泌组与非高分泌组在FEV1预计值(P = 0.038, Z = −2.073)、痰液积分(P < 0.001, Z = 6.779)存在统计学差异,有咳嗽咳痰症状的患者更有可能出现气道黏液的高分泌(OR: 9.059 [1.247~65.825], P = 0.029)。结论:在辅助检查中,两者的CT征象(慢性支气管炎样改变、肺气肿、粘液栓)和血象并未发现明显的统计学差异,中性粒细胞与淋巴细胞的比值也没有显示出统计学差异;从症状方面看,咳嗽咳痰患者出现气道黏液高分泌的可能更大;而痰液积分越高,气道黏液过多分泌的风险越大。
Abstract: Objective: Analysis of Population Characteristics and Influencing Factors in COPD Patients with Airway Mucus Hypersecretion-Type. Methods: We retrospectively collected general information, laboratory results, and imaging findings from COPD patients. Based on the St. George’s Respiratory Questionnaire (SGRQ), patients were divided into a hypersecretion group and a non-hypersecretion group, and differences between the two groups were compared. Results: A total of 84 cases meeting the inclusion criteria were included in this study, among which 34 patients were classified as having mucus hypersecretion. Statistically significant differences were observed between the hypersecretion and non-hypersecretion groups in terms of FEV1% predicted (P = 0.038, Z = −2.073) and sputum score (P < 0.001, Z = 6.779). Patients with symptoms of cough and sputum were more likely to exhibit airway mucus hypersecretion (OR: 9.059 [1.247~65.825], P = 0.029). Conclusion: No statistically significant differences were found in CT findings (such as chronic bronchitis-like changes, emphysema, and mucous plugs) or blood test results between the two groups. The neutrophil-to-lymphocyte ratio also showed no statistical difference. From a symptomatic perspective, patients with cough and sputum were more likely to have airway mucus hypersecretion. Additionally, a higher sputum score was associated with an increased risk of excessive airway mucus secretion.
文章引用:韩影杰, 李永怀. 气道黏液高分泌型COPD患者人群特征分析[J]. 临床医学进展, 2025, 15(12): 2571-2579. https://doi.org/10.12677/acm.2025.15123690

参考文献

[1] WHO (2024) Chronic Obstructive Pulmonary Disease 2024.
https://www.who.int/zh/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)#
[2] Boers, E., Allen, A., Barrett, M., Benjafield, A.V., Rice, M.B., Wedzicha, J.A., et al. (2025) Forecasting the Global Economic and Health Burden of COPD from 2025 through 2050. Chest, 168, 880-889. [Google Scholar] [CrossRef] [PubMed]
[3] Allinson, J.P., Hardy, R., Donaldson, G.C., Shaheen, S.O., Kuh, D. and Wedzicha, J.A. (2016) The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development. American Journal of Respiratory and Critical Care Medicine, 193, 662-672. [Google Scholar] [CrossRef] [PubMed]
[4] Bae, J., Lee, H.J., Choi, K.Y., Lee, J., Park, T.Y., Heo, E.Y., et al. (2024) Risk Factors of Acute Exacerbation and Disease Progression in Young Patients with COPD. BMJ Open Respiratory Research, 11, e001740. [Google Scholar] [CrossRef] [PubMed]
[5] Hughes, R., Rapsomaniki, E., Janson, C., Keen, C., Make, B.J., Burgel, P., et al. (2022) Frequent Productive Cough: Symptom Burden and Future Exacerbation Risk among Patients with Asthma and/or COPD in the NOVELTY Study. Respiratory Medicine, 200, Article ID: 106921. [Google Scholar] [CrossRef] [PubMed]
[6] Diaz, A.A., Orejas, J.L., Grumley, S., Nath, H.P., Wang, W., Dolliver, W.R., et al. (2023) Airway-Occluding Mucus Plugs and Mortality in Patients with Chronic Obstructive Pulmonary Disease. JAMA, 329, 1832-1839. [Google Scholar] [CrossRef] [PubMed]
[7] Lin, V.Y., Kaza, N., Birket, S.E., Kim, H., Edwards, L.J., LaFontaine, J., et al. (2019) Excess Mucus Viscosity and Airway Dehydration Impact COPD Airway Clearance. European Respiratory Journal, 55, Article ID: 1900419. [Google Scholar] [CrossRef] [PubMed]
[8] Mettler, S.K., Nath, H.P., Grumley, S., Orejas, J.L., Dolliver, W.R., Nardelli, P., et al. (2024) Silent Airway Mucus Plugs in COPD and Clinical Implications. Chest, 166, 1010-1019. [Google Scholar] [CrossRef] [PubMed]
[9] Tanabe, N., Shimizu, K., Shima, H., Wakazono, N., Shiraishi, Y., Terada, K., et al. (2024) Computed Tomography Mucus Plugs and Airway Tree Structure in Patients with Chronic Obstructive Pulmonary Disease: Associations with Airflow Limitation, Health‐Related Independence and Mortality. Respirology, 29, 951-961. [Google Scholar] [CrossRef] [PubMed]
[10] Dunican, E.M., Elicker, B.M., Henry, T., Gierada, D.S., Schiebler, M.L., Anderson, W., et al. (2021) Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers. American Journal of Respiratory and Critical Care Medicine, 203, 957-968. [Google Scholar] [CrossRef] [PubMed]
[11] Thompson, P.J., Criner, G.J., Dransfield, M.T., Halpin, D.M.G., Han, M.K., Lipson, D.A., et al. (2022) Effect of Chronic Mucus Hypersecretion on Treatment Responses to Inhaled Therapies in Patients with Chronic Obstructive Pulmonary Disease: Post Hoc Analysis of the IMPACT Trial. Respirology, 27, 1034-1044. [Google Scholar] [CrossRef] [PubMed]
[12] Mannino, D., Aryal, S. and Diaz, E. (2014) Influence of Sex on Chronic Obstructive Pulmonary Disease Risk and Treatment Outcomes. International Journal of Chronic Obstructive Pulmonary Disease, 9, 1145-1154. [Google Scholar] [CrossRef] [PubMed]
[13] DeMeo, D.L. (2025) Sex, Gender, and COPD. Annual Review of Physiology, 87, 471-490. [Google Scholar] [CrossRef] [PubMed]
[14] Yang, I.A., Jenkins, C.R. and Salvi, S.S. (2022) Chronic Obstructive Pulmonary Disease in Never-Smokers: Risk Factors, Pathogenesis, and Implications for Prevention and Treatment. The Lancet Respiratory Medicine, 10, 497-511. [Google Scholar] [CrossRef] [PubMed]
[15] Mohammad, Y., Rafea, S., Abou-Alzahab, B., Khaltaev, N., Dubaybo, B. and Bousquet, J. (2013) Impact of Active and Passive Smoking as Risk Factors for Asthma and COPD in Women Presenting to Primary Care in Syria: First Report by the WHO-GARD Survey Group. International Journal of Chronic Obstructive Pulmonary Disease, 8, 473-482. [Google Scholar] [CrossRef] [PubMed]
[16] Cunalata-Paredes, A.V. and Gea-Izquierdo, E. (2020) COPD in the Major Nonsmoking Adult: A Systematic Review and Meta-Analysis. Archives of Environmental & Occupational Health, 76, 319-329. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, Q. and Liu, S. (2023) The Effects and Pathogenesis of PM2.5 and Its Components on Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 18, 493-506. [Google Scholar] [CrossRef] [PubMed]
[18] Ling, S. (2009) Particulate Matter Air Pollution Exposure: Role in the Development and Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 4, 233-243. [Google Scholar] [CrossRef] [PubMed]
[19] Yu, S., Zhang, C., Yan, Z., Fang, Q. and Gao, X. (2021) Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease. Computational and Mathematical Methods in Medicine, 2021, Article ID: 1341644. [Google Scholar] [CrossRef] [PubMed]
[20] Xu, J., Zeng, Q., Li, S., Su, Q. and Fan, H. (2024) Inflammation Mechanism and Research Progress of COPD. Frontiers in Immunology, 15, Article 1404615. [Google Scholar] [CrossRef] [PubMed]
[21] Rogliani, P. and Calzetta, L. (2025) Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data from COPDGene. International Journal of Chronic Obstructive Pulmonary Disease, 20, 831-840. [Google Scholar] [CrossRef] [PubMed]